Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & GamblefiledCriticalProcter & Gamble
Priority to AR33573696ApriorityCriticalpatent/AR001226A1/en
Publication of AR001226A1publicationCriticalpatent/AR001226A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención provee métodos para tratar un sujeto humano u otro animal que tiene un trastorno del metabolismo óseo, que comprende los pasos de:(a) administrar al sujeto antes mencionado una cantidad segura y eficaz de un fosfonato óseo-activo, durante un período de por lo menos 6 meses,aproximadamente; (b) administrar al sujeto antes mencionado una cantidad segura y eficaz de una hormona paratiroidea, durante un período de 3 a 12 meses.The present invention provides methods of treating a human or other animal subject having a bone metabolism disorder, comprising the steps of: (a) administering to the aforementioned subject a safe and effective amount of a bone-active phosphonate, over a period of at least 6 months, approximately; (b) administering to the aforementioned subject a safe and effective amount of a parathyroid hormone, over a period of 3 to 12 months.
AR33573696A1996-03-131996-03-13
Methods for the treatment of osteoporosis using active phosphonates and parathyroid hormone
AR001226A1
(en)
METHOD FOR TREATING OSTEOPOROSIS, COMPOSITION FOR TREATING OSTEOPOROSIS, APPLICATION OF ACTIVE PHOSPHONATE AND ESTROGENIC HORMONE FOR TREATING OSTEOPOROSIS